Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 25,225 | 27,172 | 27,148 | 32,042 | 29,329 |
| Cost of Goods | 770 | 979 | 1,250 | 1,184 | 1,077 |
| Gross Profit | 24,455 | 26,193 | 25,898 | 30,858 | 28,252 |
| Operating Expenses | 22,031 | 19,101 | 117,780 | 18,278 | 23,355 |
| Operating Income | 3,194 | 8,071 | -91,632 | 12,764 | 4,974 |
| Other Income | 2,841 | 4,410 | -8,646 | -1,576 | 880 |
| Pre-tax Income | 6,035 | 12,481 | -100,278 | 11,188 | 5,854 |
| Income Tax | 1,497 | 2,546 | 699 | 3,678 | 2,084 |
| Net Income Continuous | 4,538 | 9,935 | -100,977 | 7,510 | 3,770 |
| Minority Interests | 1,010 | 2,403 | 29 | 3,534 | 1,917 |
| Net Income | $3,528 | $7,532 | $-101,006 | $3,976 | $1,853 |
| EPS Basic Total Ops | 0.04 | 0.09 | -1.54 | 0.06 | 0.03 |
| EPS Basic Continuous Ops | 0.05 | 0.12 | -1.54 | 0.12 | 0.06 |
| EPS Diluted Total Ops | 0.01 | 0.03 | -1.51 | 0.05 | 0.02 |
| EPS Diluted Continuous Ops | 0.04 | 0.10 | -1.49 | 0.10 | 0.05 |
| EPS Diluted Before Non-Recurring Items | 0.01 | 0.04 | N/A | N/A | N/A |
| EBITDA(a) | $3,422 | $8,486 | $-91,324 | $12,966 | $5,292 |